TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35096723

Group type: EXPERIMENTAL
Intervention: Oxygen therapy at 6 L/min for 6-12 hours
Number of subjects: 6629

Group type: COMPARATOR
Intervention: Ambient air
Number of subjects: 6629

Group type: EXPERIMENTAL
Intervention: Oxygen therapy
Number of subjects: 6629
Study: 32383771

Group type: EXPERIMENTAL
Intervention: Urinary FSH (uFSH) bolus (6 ampules, 450 IU)
Number of subjects: 732

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 732
Study: 35830201

Group type: EXPERIMENTAL
Intervention: SOC plus arbidol tablets (200 mg three times a day for 14 days)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: SOC plus arbidol tablets
Number of subjects: 99

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 99
Study: 32794087

Group type: EXPERIMENTAL
Intervention: Peer and non-peer co-facilitated intervention (Living Well)
Number of subjects: 16
Study: 34009795

Group type: EXPERIMENTAL
Intervention: Educational workshop for coaches (60-minute duration)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group received print materials only
Number of subjects: 21
Study: 33385772

Group type: EXPERIMENTAL
Intervention: Expressive arts therapy (EAT), 60-90 min, twice a week for 6 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 48
Study: 32658308

Group type: EXPERIMENTAL
Intervention: Fatty acid isotopic sentinels (FAME) prepared at a ratio of 2:1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Catalytic amounts of NaOCH3
Number of subjects: 0
Study: 35713650

Group type: EXPERIMENTAL
Intervention: Reading aloud
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Semi-occluded vocal tract exercises (SOVTE)
Number of subjects: 26

Group type: COMPARATOR
Intervention: SOVTE
Number of subjects: 26
Study: 33805948

Group type: EXPERIMENTAL
Intervention: Interferential current (IFC) application on the lumbar segment
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 73
Study: 35395840

Group type: EXPERIMENTAL
Intervention: Advice to visit the general practitioner cooperative
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nurse's advice
Number of subjects: 0
Study: 33180100

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy regimen of 36 Gy in once-daily 2-Gy fractions
Number of subjects: 79
Study: 35836691

Group type: EXPERIMENTAL
Intervention: Increased raw vegetable intake through seminars and intensive coaching weekly
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conventional diabetes diet according to the guidelines of the Indonesian Society of Endocrinology
Number of subjects: 84
Study: 33646341

Group type: EXPERIMENTAL
Intervention: Intoxicated group (mean BrAC = 0.06% at encoding, 0.07% at retrieval)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Active placebo group
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Intoxicated group
Number of subjects: 165
Study: 35997951

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (3000 mg daily in three divided doses for five days)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (standard hospital treatment only)
Number of subjects: 75
Study: 34791048

Group type: EXPERIMENTAL
Intervention: Standard RYGB (150 cm alimentary, 50 cm biliopancreatic limb)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Distal RYGB (150 cm common channel, 50 cm biliopancreatic limb)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Between-group comparison
Number of subjects: 123
Study: 34292408

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation
Number of subjects: 91

Group type: COMPARATOR
Intervention: High-flow nasal oxygen
Number of subjects: 91
Study: 33127579

Group type: EXPERIMENTAL
Intervention: Active tFUS (sonication of the right anterior thalamus)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham tFUS
Number of subjects: 19
Study: 35876109

Group type: EXPERIMENTAL
Intervention: 2,4-D herbicide at a dose of 2.04 g a.e. ha-1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low doses of 2,4-D applied at tillering stage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low doses of 2,4-D
Number of subjects: 0
Study: 34333788

Group type: EXPERIMENTAL
Intervention: Intragastric balloon therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endoscopic sleeve gastroplasty
Number of subjects: 0
Study: 32478821

Group type: EXPERIMENTAL
Intervention: Experimental intervention (various invasive cardiovascular interventions)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Nonsignificant differences in primary outcomes
Number of subjects: 216

Group type: COMPARATOR
Intervention: Commercial sponsorship
Number of subjects: 216

Group type: COMPARATOR
Intervention: Discrepancies between registered and published primary outcomes
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Patients experiencing a different outcome
Number of subjects: 216
Study: 34837259

Group type: EXPERIMENTAL
Intervention: Formula total diet replacement programme followed by structured weight loss maintenance
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Support by healthcare professionals (HCPs)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Ongoing support by research dietitians
Number of subjects: 22
Study: 33180129

Group type: EXPERIMENTAL
Intervention: AI-assisted review by pathologists
Number of subjects: 240

Group type: COMPARATOR
Intervention: Unassisted review by pathologists
Number of subjects: 240
Study: 33245323

Group type: EXPERIMENTAL
Intervention: Vigorous physical activity
Number of subjects: 7571

Group type: COMPARATOR
Intervention: Control group (no vigorous physical activity)
Number of subjects: 7571
Study: 36202942

Group type: EXPERIMENTAL
Intervention: COVID-19 associated mucormycosis (CAM) group
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: History of diabetes mellitus
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: High-dose corticosteroid pulse therapy
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: CAM group
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Expired patients in CAM group
Number of subjects: 52
Study: 32656738

Group type: EXPERIMENTAL
Intervention: Social Cognition and Interaction Training for Autism (SCIT‐A)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 41
Study: 32651286

Group type: EXPERIMENTAL
Intervention: Laquinimod 0.6 mg
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Laquinimod 1.5 mg
Number of subjects: 374

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 374
Study: 35491679

Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg oral dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32819873

Group type: EXPERIMENTAL
Intervention: Patients with non-calcified plaques (NCPs)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Patients with high-risk plaques (HRPs)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Presence of HRPs
Number of subjects: 45
Study: 34734780

Group type: EXPERIMENTAL
Intervention: Adhesive taping
Number of subjects: 28

Group type: COMPARATOR
Intervention: Tissue adhesive
Number of subjects: 28
Study: 33600580

Group type: EXPERIMENTAL
Intervention: Visual biofeedback
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Auditory biofeedback
Number of subjects: 19
Study: 32504575

Group type: EXPERIMENTAL
Intervention: Community-based intervention including enhanced HIV testing, earlier antiretroviral therapy (ART), and strengthened male circumcision services
Number of subjects: 2625

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 2625

Group type: EXPERIMENTAL
Intervention: Community-based intervention
Number of subjects: 2625
Study: 35932269

Group type: EXPERIMENTAL
Intervention: Unilateral MRI-guided focused ultrasound (MRgFUS) thalamotomy
Number of subjects: 45
Study: 33884609

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 mcg/kg/h) in PRD group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline solution (SS) in PR group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 mcg/kg/h) in substudy 2
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline solution (SS) in substudy 2
Number of subjects: 40
Study: 32739974

Group type: EXPERIMENTAL
Intervention: Valaciclovir at a dose of 8g/day
Number of subjects: 2

Group type: COMPARATOR
Intervention: CMV hyperimmune globulin (HIG)
Number of subjects: 2
Study: 36624180

Group type: EXPERIMENTAL
Intervention: Dexamethasone (6 mg once a day)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Methylprednisolone (16 mg twice a day)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Hydrocortisone (50 mg thrice a day)
Number of subjects: 106
Study: 34788432

Group type: EXPERIMENTAL
Intervention: PVAC Gold group
Number of subjects: 75

Group type: COMPARATOR
Intervention: ST‐CF
Number of subjects: 75
Study: 32036290

Group type: EXPERIMENTAL
Intervention: Fostering Connections program (group-based experiential intervention) delivered over 6 weeks
Number of subjects: 79

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Fostering Connections program
Number of subjects: 79
Study: 33779523

Group type: EXPERIMENTAL
Intervention: Presence of humor
Number of subjects: 326

Group type: COMPARATOR
Intervention: Absence of humor
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Presence of humor (Men)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Presence of humor (Women)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Bystander gender
Number of subjects: 326
Study: 34383533

Group type: EXPERIMENTAL
Intervention: Adaptive Preventive Intervention (API)
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: Resource email
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: Any API
Number of subjects: 891

Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 891
Study: 33367869

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 3000 IU daily
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 25,000 IU weekly
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 100,000 IU monthly
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 1000 IU daily (maintenance course)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study: 32948747

Group type: EXPERIMENTAL
Intervention: discordant condition (safe and risky choices followed by angry and happy faces)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: concordant condition (safe and risky choices followed by happy and angry faces)
Number of subjects: 116
Study: 35914913

Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment (CGA) and multidisciplinary intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 0
Study: 34271882

Group type: EXPERIMENTAL
Intervention: mHealth intervention (LIFE4YOUth) consisting of recurring screening, text messages, and an interactive platform
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group for 4 months
Number of subjects: 0
Study: 34009912

Group type: EXPERIMENTAL
Intervention: Dyad training
Number of subjects: 101

Group type: COMPARATOR
Intervention: Individual training
Number of subjects: 101
Study: 34022947

Group type: EXPERIMENTAL
Intervention: Hand hygiene device attached to a computer on wheels (COW)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (no hand hygiene device)
Number of subjects: 39
Study: 35551495

Group type: EXPERIMENTAL
Intervention: Noninvasive diabetes risk score applied in primary care as an add-on to standard routine health checks.
Number of subjects: 315

Group type: COMPARATOR
Intervention: Standard routine health checks without the diabetes risk score.
Number of subjects: 315
Study: 34468743

Group type: EXPERIMENTAL
Intervention: Bovine rotavirus pentavalent vaccine (Rotasiil)
Number of subjects: 1729

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1729
Study: 34344556

Group type: EXPERIMENTAL
Intervention: Microabrasion
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Resin-infiltration
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control
Number of subjects: 27
Study: 32749877

Group type: EXPERIMENTAL
Intervention: Motivational-interviewing (MI) intervention over 24 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brief education
Number of subjects: 0
Study: 36107632

Group type: EXPERIMENTAL
Intervention: FASTER-assisted ESD (FC group)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Conventional ESD (CF group)
Number of subjects: 4
Study: 34971054

Group type: EXPERIMENTAL
Intervention: AAC Plus device
Number of subjects: 0
Study: 35247524

Group type: EXPERIMENTAL
Intervention: Restricted gestational weight gain (GWG)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Excessive gestational weight gain (GWG)
Number of subjects: 460
Study: 32162282

Group type: COMPARATOR
Intervention: Income Assistance
Number of subjects: 21

Group type: COMPARATOR
Intervention: Federal Maternity Benefits based on minimum wage
Number of subjects: 21

Group type: COMPARATOR
Intervention: $15/h wage
Number of subjects: 21
Study: 36161538

Group type: EXPERIMENTAL
Intervention: Ireland
Number of subjects: 25928

Group type: COMPARATOR
Intervention: Denmark
Number of subjects: 25928
Study: 33179374

Group type: EXPERIMENTAL
Intervention: Takotsubo syndrome (TTS) patients
Number of subjects: 32

Group type: COMPARATOR
Intervention: Controls (age- and sex-matched)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Acute coronary syndrome (ACS) patients
Number of subjects: 32
Study: 32331008

Group type: EXPERIMENTAL
Intervention: Aripiprazole once-monthly 400 mg (AOM 400)
Number of subjects: 464
Study: 36168186

Group type: EXPERIMENTAL
Intervention: Transcarotid artery revascularization (TCAR)
Number of subjects: 851

Group type: COMPARATOR
Intervention: Control group (younger patients)
Number of subjects: 851
Study: 34582438

Group type: EXPERIMENTAL
Intervention: Philani MObile Video Intervention for Exclusive breastfeeding (MOVIE) delivered by community health workers (CHWs) during home visits; replaced about 40% of CHWs' direct engagement time with participants.
Number of subjects: 1502

Group type: COMPARATOR
Intervention: Standard of care counseling provided by mentor mothers in the control arm.
Number of subjects: 1502
Study: 33065472

Group type: EXPERIMENTAL
Intervention: Neurofeedback (NFB) training targeting sensorimotor α‐oscillations
Number of subjects: 45
Study: 36221135

Group type: EXPERIMENTAL
Intervention: Early coagulopathy (defined by INR, platelets, APTT abnormalities)
Number of subjects: 227
Study: 34029219

Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) materials
Number of subjects: 33

Group type: COMPARATOR
Intervention: Paper-based materials
Number of subjects: 33
Study: 35569753

Group type: EXPERIMENTAL
Intervention: Heal-Me app + virtual group dietitian/exercise-specialist sessions
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Heal-Me app + virtual group and 1-to-1 dietitian/exercise-specialist sessions
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control: educational material
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 216
Study: 33350455

Group type: EXPERIMENTAL
Intervention: HPV self-test
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard care - cervical smear
Number of subjects: 500
Study: 32563173

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Adverse childhood experiences (ACEs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham depletion
Number of subjects: 40
Study: 33486536

Group type: EXPERIMENTAL
Intervention: en-bloc enucleation
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: two-lobe enucleation
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: three-lobe enucleation
Number of subjects: 600

Group type: COMPARATOR
Intervention: en-bloc vs. two-lobe enucleation
Number of subjects: 600
Study: 32418217

Group type: EXPERIMENTAL
Intervention: Ball-end probe tip (0.6 mm diameter, 408 kPa)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Straight probe tip (0.45 mm diameter, 726 kPa)
Number of subjects: 20
Study: 34364301

Group type: EXPERIMENTAL
Intervention: Low-volume walking HIIT (75 min/week)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Moderate-intensity continuous training (MICT) (150 min/week)
Number of subjects: 30
Study: 34291331

Group type: EXPERIMENTAL
Intervention: Iron supplementation (2 mg/kg/day of iron pidolate) from the third week of life to 6 months of post-conceptional age
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 33531017

Group type: EXPERIMENTAL
Intervention: Illness script method intervention; taught clinical reasoning skills for three diseases during one clinical scenario
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group; taught clinical presentation based on signs and symptoms of the same three diseases
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Illness script method intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 33020411

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (Hyp, n = 10)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intermittent normoxia (Norm, n = 9)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (Hyp)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intermittent normoxia (Norm)
Number of subjects: 19
Study: 36424705

Group type: EXPERIMENTAL
Intervention: Para-aortic lymphadenectomy (PALD)
Number of subjects: 728

Group type: COMPARATOR
Intervention: No para-aortic lymphadenectomy (Control)
Number of subjects: 728
Study: 33522667

Group type: EXPERIMENTAL
Intervention: Short stitch (SS)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Long stitch (LS)
Number of subjects: 86
Study: 34648118

Group type: EXPERIMENTAL
Intervention: Epirubicin plus cyclophosphamide followed by taxanes (ECT)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Carboplatin plus taxanes (TP)
Number of subjects: 308

Group type: COMPARATOR
Intervention: TP in SPARC (> 50%) subgroup
Number of subjects: 308

Group type: COMPARATOR
Intervention: ECT in SPARC (≤ 50%), PD-L1 (-), PD-L1 (+), BRCA mutation or BRCA wild
Number of subjects: 308
Study: 36175142

Group type: EXPERIMENTAL
Intervention: Lower serum free testosterone
Number of subjects: 2741

Group type: EXPERIMENTAL
Intervention: Higher SHBG
Number of subjects: 2741

Group type: COMPARATOR
Intervention: Cinacalcet treatment
Number of subjects: 2741

Group type: EXPERIMENTAL
Intervention: Total testosterone
Number of subjects: 2741

Group type: EXPERIMENTAL
Intervention: Free testosterone
Number of subjects: 2741

Group type: EXPERIMENTAL
Intervention: SHBG
Number of subjects: 2741
Study: 34241628

Group type: EXPERIMENTAL
Intervention: Gamification with financial incentives
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Gamification without financial incentives
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Gamification with social support
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Gamification with social support and loss-framed financial incentive
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 32143995

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic and resistance exercise program
Number of subjects: 48

Group type: COMPARATOR
Intervention: Personal training, supervised group exercise, or home-based exercise (combined for primary analysis)
Number of subjects: 48
Study: 36028192

Group type: EXPERIMENTAL
Intervention: Proactive panel management using the VA's HF dashboard
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study: 34724895

Group type: EXPERIMENTAL
Intervention: Adequate follow-up requests
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Inadequate follow-up requests
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Medication reviews during hospitalisation
Number of subjects: 699
Study: 32232482

Group type: EXPERIMENTAL
Intervention: NCCN-IPI
Number of subjects: 2124

Group type: COMPARATOR
Intervention: IPI
Number of subjects: 2124

Group type: COMPARATOR
Intervention: R-IPI
Number of subjects: 2124
Study: 34672898

Group type: EXPERIMENTAL
Intervention: Cangrelor (intravenous P2Y12 receptor antagonist) as a bridging therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standardized bridging protocol with cangrelor
Number of subjects: 0
Study: 34955035

Group type: EXPERIMENTAL
Intervention: Foot Reflexology
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control
Number of subjects: 105
Study: 32703680

Group type: EXPERIMENTAL
Intervention: Parental education
Number of subjects: 129

Group type: COMPARATOR
Intervention: Daily activities (Control)
Number of subjects: 129
Study: 35771740

Group type: EXPERIMENTAL
Intervention: Smartphone application intervention group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 33277680

Group type: EXPERIMENTAL
Intervention: Hemopatch®
Number of subjects: 45
Study: 35390113

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 600
Study: 36351419

Group type: EXPERIMENTAL
Intervention: Static posturography‐assisted biofeedback exercises (n = 20)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional exercise program (n = 21)
Number of subjects: 48
Study: 33745137

Group type: EXPERIMENTAL
Intervention: Balloon‐occluded retrograde transvenous obliteration (BRTO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyanoacrylate glue injection
Number of subjects: 0
Study: 35615236

Group type: EXPERIMENTAL
Intervention: NIRS protocol with 8 interventions (increase cardiac output, normocapnia, increase mean arterial pressure, increase inspired oxygen, depth of anaesthesia, blood transfusion, correction of bypass cannula, change of surgical plan)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: NIRS protocol
Number of subjects: 182

Group type: COMPARATOR
Intervention: Standard management without NIRS
Number of subjects: 182
Study: 34400208

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 166
Study: 32436655

Group type: EXPERIMENTAL
Intervention: Digital, continuous pump‐driven chest drainage system
Number of subjects: 120

Group type: COMPARATOR
Intervention: Traditional wall‐suction system
Number of subjects: 120